The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwMyeloma 2015 | Early treatment and novel therapeutic targets for multiple myeloma
Antonio Palumbo, Jesús San Miguel and Keith Stewart
• 11 Apr 2015
At the Myeloma 2015 meeting, Dr Keith Stewart (Mayo Clinic, Scottsdale, AZ) chairs a discussion with Prof Jesús San Miguel (University of Salamanca, Salamanca, Spain) and Prof Antonio Palumbo (University of Torino, Torino, Italy) on new studies of the role of early intervention for smoldering multiple myeloma (MM), treatment strategies for high-risk MM, and promising novel agents for MM.
